References
Maguiness S, Guenther L. Kasabach–Merritt syndrome. J Cutan Med Surg. 2002;6:335–9.
Hall GW. Kasabach–Merriitt syndrome: pathogenesis and management. Br J Haematol. 2001;112:851–62.
Haisley-Royster C, Enjolras O, Frieden IJ, et al. Kasabach–Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol. 2002;24:459–62.
Taki M, Ohi C, Yamashita A, et al. Successful treatment with vincristine of an infant with intractable Kasabach–Merritt syndrome. Pediatr Int. 2006;48:82–4.
William MC, James RA, Jane LM, et al., Beverly Raney and Frederick B. Ruymann et al. Intergroup Rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19:3091–102.
Wananuku IS, Nuchprayoon I, Seksarn P. Treatment of Kasabach–Merritt syndrome: a stepwise regimen of prednisolone, dipyridamole, and interferon. Int J Dermatol. 2003;42:741–8.
Drucker AM, Pope E, Mahant S, et al. Vincristine and corticosteroids as first-line treatment of Kasabach–Merritt syndrome in kaposiform hemangioendothelioma. J Cutan Med Surg. 2009;13:155–9.
Hara K, Yoshida T, Kajiume T, et al. Successful treatment of Kasabach–Merritt syndrome with vincristine and diagnosis of the hemangioma using three-dimensional imaging. Pediatr Hematol Oncol. 2009;26:375–80.
Ogino I, Torikai K, Kobayasi S, et al. Radiation therapy for life- or function-threatening infant hemangioma. Radiology. 2001;218:834–9.
Mitsuhashi N, Furuta M, Sakurai H, et al. Outcome of therapy for patients with Kasabach–Merritt syndrome. Int J Radiat Oncol Biol Phys. 1997;39:467–73.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Watanabe, Y., Onuma, M., Looi, C.Y. et al. Vincristine-resistant Kasabach–Merritt phenomenon successfully treated with low-dose radiotherapy. Int J Hematol 93, 126–128 (2011). https://doi.org/10.1007/s12185-010-0740-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-010-0740-4